目的探讨Rho激酶抑制剂法舒地尔对大鼠脑缺血再灌注损伤后的保护作用及可能机制。方法健康成年雄性SD大鼠90只,随机分为3组:假手术组、模型组、法舒地尔组,每组30只,每组再按照再灌注时间不同分为6、12、24 h 3个时间点,每个时间点10只...目的探讨Rho激酶抑制剂法舒地尔对大鼠脑缺血再灌注损伤后的保护作用及可能机制。方法健康成年雄性SD大鼠90只,随机分为3组:假手术组、模型组、法舒地尔组,每组30只,每组再按照再灌注时间不同分为6、12、24 h 3个时间点,每个时间点10只,线栓法制作大鼠大脑中动脉缺血再灌注损伤模型。术后对大鼠进行神经功能评分,RT-PCR检测缺血侧脑组织中新型趋化因子mRNA、NF-κB p65 mRNA表达。结果与假手术组比较,模型组和法舒地尔组大鼠脑缺血再灌注6、12、24 h NF-κB3 p65 mRNA、新型趋化因子mRNA表达明显升高,差异有统计学意义(P<0.05);与模型组比较,法舒地尔组大鼠脑缺血再灌注6、12、24 h神经功能缺损评分明显降低,12、24 h NF-κB p65 mRNA、新型趋化因子mRNA表达明显降低,差异有统计学意义(P<0.05,P<0.01)。结论法舒地尔的脑保护作用可能与其减轻大鼠脑缺血再灌注损伤后的炎性反应有关。展开更多
Regenerative capacity is weak after central nervous system injury because of the absence of an enhancing microenvironment and presence of an inhibitory microenvironment for neuronal and axonal repair. In addition to t...Regenerative capacity is weak after central nervous system injury because of the absence of an enhancing microenvironment and presence of an inhibitory microenvironment for neuronal and axonal repair. In addition to the Nogo receptor(Ng R), the paired immunoglobulin-like receptor B(Pir B) is a recently discovered coreceptor of Nogo, myelin-associated glycoprotein, and myelin oligodendrocyte glycoprotein. Concurrent blocking of Ng R and Pir B almost completely eliminates the inhibitory effect of myelin-associated inhibitory molecules on axonal regeneration. Pir B participates in a key pathological process of the nervous system, specifically axonal regeneration inhibition. Pir B is an inhibitory receptor similar to Ng R, but their effects are not identical. This study summarizes the structure, distribution, relationship with common nervous system diseases, and known mechanisms of Pir B, and concludes that Pir B is also distributed in cells of the immune and hematopoietic systems. Further investigations are needed to determine if immunomodulation and blood cell migration involve inhibition of axonal regeneration.展开更多
Background Hypoxic pulmonary hypertension (HPH) contributes to the pathogenesis of cardiopulmonary diseases.Several lines of evidence indicate that the Rho A/Rho-kinase pathway play an important role in the progress...Background Hypoxic pulmonary hypertension (HPH) contributes to the pathogenesis of cardiopulmonary diseases.Several lines of evidence indicate that the Rho A/Rho-kinase pathway play an important role in the progress of pulmonary hypertension.Stains have been shown exert numerous biological effects that are independent of their cholesterollowering property.We hypothesized that the Rho A/Rho-kinase pathway is involved in the pathogenesis of HPH,and that atorvastatin would attenuate involvement of the Rho A/Rho-kinase pathway in a HPH rat model.Methods Thirty-two Wistar rats were randomly divided into four groups:control group,hypoxic group,atovastatin group,and normal saline group.The control group was kept in a normoxia environment.The other groups were exposed to hypoxia for three weeks.Atovastatin was administered daily via a gastric gavage in the atovastatin group.We measured the mean pulmonary arterial pressure (mPAP),the ratio of the right ventricular weight to the sum of the weights of the left heart ventricle and septum (RV/(LV+S)),arteriole wall thickness/vascular external diameter (WT%),vascular area/total vascular area (WA%),expression of RhoA and phos-MYPT-1 protein in lung tissue,and NF-κB activation in pulmonary vascular smooth muscle cells.Results Compared with the control group,mPAP,RV/(LV+S),WT%,WA%,NF-κB activation,expression of RhoA,and phos-MYPT-1 were increased in the hypoxic and normal saline groups (P <0.05).Compared with the hypoxic group,mPAP,RV/(LV+S),WT%,WA%,NF-κB activation,expression of RhoA,and phos-MYPT-1 were decreased in the atovastatin group (P <0.05).Correlations between phos-MPTY-1 and mPAP,WA%,WT%,and NF-κB activation were all positive.Conclusions The Rho NRho-kinase pathway plays an important role in the development of HPH.Atorvastatin reversed HPH by inhibiting the activity of Rho A/Rho-kinase and NF-κB.展开更多
Background:MicroRNAs are closely associated with the progression and outcomes of multiple human diseases,including sepsis.In this study,we examined the role of miR-23a in septic injury.Methods Lipopolysaccharide(LPS)w...Background:MicroRNAs are closely associated with the progression and outcomes of multiple human diseases,including sepsis.In this study,we examined the role of miR-23a in septic injury.Methods Lipopolysaccharide(LPS)was used to induce sepsis in a rat model and H9C2 and HK-2 cells.miR-23a expression was evaluated in rat myocardial and kidney tissues,as well as H9C2 and HK-2 cells.A miR-23a mimic was introduced into cells to identify the role of miR-23a in cell viability,apoptosis,and the secretion of inflammatory cytokines.Furthermore,the effect of Rho-associated kinase 1(ROCK1),a miR-23a target,on cell damage was evaluated,and molecules involved in the underlying mechanism were identified.Results:In the rat model,miR-23a was poorly expressed in myocardial(sham vs.sepsis 1.00±0.06 vs.0.27±0.03,P<0.01)and kidney tissues(sham vs.sepsis 0.27±0.03 vs.1.00±0.06,P<0.01).Artificial overexpression of miR-23a resulted in increased proliferative activity(DNA replication rate:Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:34.13±3.12 vs.12.94±1.21 vs.13.31±1.43 vs.22.94±2.26,P<0.05;HK-2 cells:15.17±1.43 vs.34.52±3.46 vs.35.19±3.12 vs.19.87±1.52,P<0.05),decreased cell apoptosis(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:11.39±1.04 vs.32.57±2.29 vs.33.08±3.12 vs.21.63±2.35,P<0.05;HK-2 cells:15.17±1.43 vs.34.52±3.46 vs.35.19±3.12 vs.19.87±1.52,P<0.05),and decreased production of inflammatory cytokines,including interleukin-6(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:59.61±5.14 vs.113.54±12.30 vs.116.51±10.69 vs.87.69±2.97 ng/mL;P<0.05,F=12.67,HK-2 cells:68.12±6.44 vs.139.65±16.62 vs.143.51±13.64 vs.100.82±9.74 ng/mL,P<0.05,F=9.83)and tumor necrosis factor-α(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:103.20±10.31 vs.169.67±18.84 vs.173.61±15.91 vs.133.36±12.32 ng/mL,P<0.05,F=12.67,HK-2 cells:132.51±13.37 vs.187.47±16.74 vs.143.51±13.64 vs.155.79±15.31 ng/mL,P<0.05,F=9.83)in cells.However,ROCK1 was identified as a miR-23a target,and further up-regulation of ROCK1 mitigated the protective function of miR-23a in LPS-treated H9C2 and HK-2 cells.Moreover,ROCK1 suppressed sirtuin-1(SIRT1)expression to promote the phosphorylation of nuclear factor-kappa B(NF-κB)p65,indicating the possible involvement of this signaling pathway in miR-23a-mediated events.Conclusion:Our results indicate that miR-23a could suppress LPS-induced cell damage and inflammatory cytokine secretion by binding to ROCK1,mediated through the potential participation of the SIRT1/NF-κB signaling pathway.展开更多
文摘目的探讨Rho激酶抑制剂法舒地尔对大鼠脑缺血再灌注损伤后的保护作用及可能机制。方法健康成年雄性SD大鼠90只,随机分为3组:假手术组、模型组、法舒地尔组,每组30只,每组再按照再灌注时间不同分为6、12、24 h 3个时间点,每个时间点10只,线栓法制作大鼠大脑中动脉缺血再灌注损伤模型。术后对大鼠进行神经功能评分,RT-PCR检测缺血侧脑组织中新型趋化因子mRNA、NF-κB p65 mRNA表达。结果与假手术组比较,模型组和法舒地尔组大鼠脑缺血再灌注6、12、24 h NF-κB3 p65 mRNA、新型趋化因子mRNA表达明显升高,差异有统计学意义(P<0.05);与模型组比较,法舒地尔组大鼠脑缺血再灌注6、12、24 h神经功能缺损评分明显降低,12、24 h NF-κB p65 mRNA、新型趋化因子mRNA表达明显降低,差异有统计学意义(P<0.05,P<0.01)。结论法舒地尔的脑保护作用可能与其减轻大鼠脑缺血再灌注损伤后的炎性反应有关。
基金supported by the National Natural Science Foundation of China,No.81170577
文摘Regenerative capacity is weak after central nervous system injury because of the absence of an enhancing microenvironment and presence of an inhibitory microenvironment for neuronal and axonal repair. In addition to the Nogo receptor(Ng R), the paired immunoglobulin-like receptor B(Pir B) is a recently discovered coreceptor of Nogo, myelin-associated glycoprotein, and myelin oligodendrocyte glycoprotein. Concurrent blocking of Ng R and Pir B almost completely eliminates the inhibitory effect of myelin-associated inhibitory molecules on axonal regeneration. Pir B participates in a key pathological process of the nervous system, specifically axonal regeneration inhibition. Pir B is an inhibitory receptor similar to Ng R, but their effects are not identical. This study summarizes the structure, distribution, relationship with common nervous system diseases, and known mechanisms of Pir B, and concludes that Pir B is also distributed in cells of the immune and hematopoietic systems. Further investigations are needed to determine if immunomodulation and blood cell migration involve inhibition of axonal regeneration.
文摘Background Hypoxic pulmonary hypertension (HPH) contributes to the pathogenesis of cardiopulmonary diseases.Several lines of evidence indicate that the Rho A/Rho-kinase pathway play an important role in the progress of pulmonary hypertension.Stains have been shown exert numerous biological effects that are independent of their cholesterollowering property.We hypothesized that the Rho A/Rho-kinase pathway is involved in the pathogenesis of HPH,and that atorvastatin would attenuate involvement of the Rho A/Rho-kinase pathway in a HPH rat model.Methods Thirty-two Wistar rats were randomly divided into four groups:control group,hypoxic group,atovastatin group,and normal saline group.The control group was kept in a normoxia environment.The other groups were exposed to hypoxia for three weeks.Atovastatin was administered daily via a gastric gavage in the atovastatin group.We measured the mean pulmonary arterial pressure (mPAP),the ratio of the right ventricular weight to the sum of the weights of the left heart ventricle and septum (RV/(LV+S)),arteriole wall thickness/vascular external diameter (WT%),vascular area/total vascular area (WA%),expression of RhoA and phos-MYPT-1 protein in lung tissue,and NF-κB activation in pulmonary vascular smooth muscle cells.Results Compared with the control group,mPAP,RV/(LV+S),WT%,WA%,NF-κB activation,expression of RhoA,and phos-MYPT-1 were increased in the hypoxic and normal saline groups (P <0.05).Compared with the hypoxic group,mPAP,RV/(LV+S),WT%,WA%,NF-κB activation,expression of RhoA,and phos-MYPT-1 were decreased in the atovastatin group (P <0.05).Correlations between phos-MPTY-1 and mPAP,WA%,WT%,and NF-κB activation were all positive.Conclusions The Rho NRho-kinase pathway plays an important role in the development of HPH.Atorvastatin reversed HPH by inhibiting the activity of Rho A/Rho-kinase and NF-κB.
文摘Background:MicroRNAs are closely associated with the progression and outcomes of multiple human diseases,including sepsis.In this study,we examined the role of miR-23a in septic injury.Methods Lipopolysaccharide(LPS)was used to induce sepsis in a rat model and H9C2 and HK-2 cells.miR-23a expression was evaluated in rat myocardial and kidney tissues,as well as H9C2 and HK-2 cells.A miR-23a mimic was introduced into cells to identify the role of miR-23a in cell viability,apoptosis,and the secretion of inflammatory cytokines.Furthermore,the effect of Rho-associated kinase 1(ROCK1),a miR-23a target,on cell damage was evaluated,and molecules involved in the underlying mechanism were identified.Results:In the rat model,miR-23a was poorly expressed in myocardial(sham vs.sepsis 1.00±0.06 vs.0.27±0.03,P<0.01)and kidney tissues(sham vs.sepsis 0.27±0.03 vs.1.00±0.06,P<0.01).Artificial overexpression of miR-23a resulted in increased proliferative activity(DNA replication rate:Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:34.13±3.12 vs.12.94±1.21 vs.13.31±1.43 vs.22.94±2.26,P<0.05;HK-2 cells:15.17±1.43 vs.34.52±3.46 vs.35.19±3.12 vs.19.87±1.52,P<0.05),decreased cell apoptosis(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:11.39±1.04 vs.32.57±2.29 vs.33.08±3.12 vs.21.63±2.35,P<0.05;HK-2 cells:15.17±1.43 vs.34.52±3.46 vs.35.19±3.12 vs.19.87±1.52,P<0.05),and decreased production of inflammatory cytokines,including interleukin-6(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:59.61±5.14 vs.113.54±12.30 vs.116.51±10.69 vs.87.69±2.97 ng/mL;P<0.05,F=12.67,HK-2 cells:68.12±6.44 vs.139.65±16.62 vs.143.51±13.64 vs.100.82±9.74 ng/mL,P<0.05,F=9.83)and tumor necrosis factor-α(Control vs.LPS vs.LPS+Mock vs.LPS+miR-23a:H9C2 cells:103.20±10.31 vs.169.67±18.84 vs.173.61±15.91 vs.133.36±12.32 ng/mL,P<0.05,F=12.67,HK-2 cells:132.51±13.37 vs.187.47±16.74 vs.143.51±13.64 vs.155.79±15.31 ng/mL,P<0.05,F=9.83)in cells.However,ROCK1 was identified as a miR-23a target,and further up-regulation of ROCK1 mitigated the protective function of miR-23a in LPS-treated H9C2 and HK-2 cells.Moreover,ROCK1 suppressed sirtuin-1(SIRT1)expression to promote the phosphorylation of nuclear factor-kappa B(NF-κB)p65,indicating the possible involvement of this signaling pathway in miR-23a-mediated events.Conclusion:Our results indicate that miR-23a could suppress LPS-induced cell damage and inflammatory cytokine secretion by binding to ROCK1,mediated through the potential participation of the SIRT1/NF-κB signaling pathway.